Sulaymonov S.A., Nuriddinov N.N., Ochilov I.A. (2026). DAPAGLIFLOZIN AS PART OF COMBINATION THERAPY IN COPD COMORBID WITH HEART FAILURE: EFFECTS ON PULMONARY, CARDIAC, RENAL AND ENDOTHELIAL FUNCTION. International Multidisciplinary Journal for Research & Development, 13(4), 76–86. Retrieved from https://www.ijmrd.in/index.php/imjrd/article/view/5501